ReposiTrak Inc. (NYSE:TRAK - Get Free Report) CEO Randall Fields sold 3,500 shares of ReposiTrak stock in a transaction dated Monday, March 9th. The stock was sold at an average price of $8.56, for a total value of $29,960.00. Following the sale, the chief executive officer directly owned 89,000 shares in the company, valued at approximately $761,840. This trade represents a 3.78% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.
ReposiTrak Stock Down 2.1%
ReposiTrak stock traded down $0.18 during trading hours on Wednesday, hitting $8.21. The stock had a trading volume of 107,644 shares, compared to its average volume of 112,309. The company has a 50-day moving average of $10.30 and a two-hundred day moving average of $13.31. The company has a market cap of $149.45 million, a PE ratio of 22.19 and a beta of 0.49. ReposiTrak Inc. has a fifty-two week low of $8.09 and a fifty-two week high of $23.72.
ReposiTrak (NYSE:TRAK - Get Free Report) last announced its quarterly earnings data on Tuesday, February 17th. The company reported $0.09 EPS for the quarter. The company had revenue of $5.86 million during the quarter. ReposiTrak had a return on equity of 14.52% and a net margin of 30.62%.
Hedge Funds Weigh In On ReposiTrak
A number of hedge funds have recently modified their holdings of TRAK. BNP Paribas Financial Markets boosted its stake in ReposiTrak by 63.5% in the 2nd quarter. BNP Paribas Financial Markets now owns 1,633 shares of the company's stock valued at $32,000 after buying an additional 634 shares in the last quarter. State of Alaska Department of Revenue raised its stake in ReposiTrak by 152.6% during the fourth quarter. State of Alaska Department of Revenue now owns 2,127 shares of the company's stock worth $25,000 after acquiring an additional 1,285 shares in the last quarter. Tower Research Capital LLC TRC raised its stake in ReposiTrak by 397.3% during the second quarter. Tower Research Capital LLC TRC now owns 3,620 shares of the company's stock worth $71,000 after acquiring an additional 2,892 shares in the last quarter. Copeland Capital Management LLC bought a new position in shares of ReposiTrak during the third quarter valued at $54,000. Finally, Flagship Harbor Advisors LLC bought a new position in shares of ReposiTrak during the fourth quarter valued at $53,000. 27.35% of the stock is owned by institutional investors and hedge funds.
Analysts Set New Price Targets
TRAK has been the topic of a number of recent research reports. Wall Street Zen downgraded shares of ReposiTrak from a "buy" rating to a "hold" rating in a research note on Saturday, January 17th. Weiss Ratings reaffirmed a "hold (c+)" rating on shares of ReposiTrak in a report on Monday, December 29th. One research analyst has rated the stock with a Hold rating, According to MarketBeat, the stock currently has an average rating of "Hold".
View Our Latest Analysis on TRAK
ReposiTrak Company Profile
(
Get Free Report)
ReposiTrak, trading on the New York Stock Exchange under the symbol TRAK, is a provider of cloud-based supply chain compliance and transparency solutions. The company's platform enables retailers, suppliers and manufacturers to manage, share and validate product data throughout the supply chain. Through its Software-as-a-Service (SaaS) offering, ReposiTrak helps organizations ensure adherence to regulatory requirements, industry standards and retailer-specific guidelines for food safety, sustainability, labeling and quality assurance.
At the core of ReposiTrak's offerings is its DataHub, a centralized repository that captures critical information such as product specifications, certifications, catch-weight data, temperature logs and recall notifications.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider ReposiTrak, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ReposiTrak wasn't on the list.
While ReposiTrak currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link to see MarketBeat's list of ten stocks that are set to soar in 2026, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.